Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 209-212 , July 2007

Utility of cardiac MRI in guiding revascularization therapy in unprotected left main stenosis: a case report

  • William M. Suh

      Affiliations

    • Division of Cardiology, The University of California, Irvine Medical Center, Orange, CA, USA
  • ,
  • Steven J. Fowler

      Affiliations

    • Division of Cardiology, The University of California, Irvine Medical Center, Orange, CA, USA
  • ,
  • James B. Wallis

      Affiliations

    • Division of Cardiology, Veterans Administration Long Beach Medical Center, Long Beach, CA, USA
  • ,
  • Morton J. Kern

      Affiliations

    • Division of Cardiology, The University of California, Irvine Medical Center, Orange, CA, USA
  • ,
  • Chowdhury H. Ahsan

      Affiliations

    • Division of Cardiology, The University of California, Irvine Medical Center, Orange, CA, USA
    • Corresponding Author InformationCorresponding author. Division of Cardiology, University of California, Irvine Medical Center, Orange, CA 92868-4080, USA. Tel.: +1 714 456 7589; fax: +1 714 456 8895.

Received 18 March 2007 ,Accepted 20 March 2007.

References 

  1. Giannoglou GD, Antoniadis AP, Chatzizisis YS, Damvopoulou E, Parcharidis GE, Louridas GE. Prevalence of narrowing > or =50% of the left main coronary artery among 17,300 patients having coronary angiography. Am J Cardiol. 2006;98(9):1202–1205
  2. Eagle KA, Guyton RA, Davidoff R, Edwards FH, Ewy GA, Gardner TJ, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation. 2004;110(14):e340–e437
  3. Lee BK, Hong MK, Lee CW, Choi BR, Kim MJ, Park KH, et al. Five-year outcomes after stenting of unprotected left main coronary artery stenosis in patients with normal left ventricular function. Int J Cardiol. 2007;115(2):208–213
  4. Chieffo A, Morici N, Maisano F, Bonizzoni E, Cosgrave J, Montorfano M, et al. Percutaneous treatment with drug-eluting stent implantation versus bypass surgery for unprotected left main stenosis: a single-center experience. Circulation. 2006;113(21):2542–2547
  5. Lee MS, Kapoor N, Jamal F, Czer L, Aragon J, Forrester J, et al. Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease. J Am Coll Cardiol. 2006;47(4):864–870
  6. Bavry AA, Kumbhani DJ, Helton TJ, Borek PP, Mood GR, Bhatt DL. Late thrombosis of drug-eluting stents: a meta-analysis of randomized clinical trials. Am J Med. 2006;119(12):1056–1061
  7. Perin EC, Silva GV, Sarmento-Leite R, Sousa AL, Howell M, Muthupillai R, et al. Assessing myocardial viability and infarct transmurality with left ventricular electromechanical mapping in patients with stable coronary artery disease: validation by delayed-enhancement magnetic resonance imaging. Circulation. 2002;106(8):957–961
  8. Kim RJ, Manning WJ. Viability assessment by delayed enhancement cardiovascular magnetic resonance: will low-dose dobutamine dull the shine?. Circulation. 2004;109(21):2476–2479
  9. Isbell DC, Kramer CM. Magnetic resonance for the assessment of myocardial viability. Curr Opin Cardiol. 2006;21(5):469–472
  10. Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ. Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357(9249):21–28
  11. Albert TS, Kim RJ, Judd RM. Assessment of no-reflow regions using cardiac MRI. Basic Res Cardiol. 2006;101(5):383–390
  12. Ricciardi MJ, Wu E, Davidson CJ, Choi KM, Klocke FJ, Bonow RO, et al. Visualization of discrete microinfarction after percutaneous coronary intervention associated with mild creatine kinase-MB elevation. Circulation. 2001;103(23):2780–2783
  13. Haase J, Bayar R, Hackenbroch M, Storger H, Hofmann M, Schwarz CE, et al. Relationship between size of myocardial infarctions assessed by delayed contrast-enhanced MRI after primary PCI, biochemical markers, and time to intervention. J Interv Cardiol. 2004;17(6):367–373
  14. Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O, et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1445–1453
  15. Bello D, Fieno DS, Kim RJ, Pereles FS, Passman R, Song G, et al. Infarct morphology identifies patients with substrate for sustained ventricular tachycardia. J Am Coll Cardiol. 2005;45(7):1104–1108
  16. Loop FD, Lytle BW, Cosgrove DM, Stewart RW, Goormastic M, Williams GW, et al Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med. 1986;314(1):1–6
  17. Huang HW, Brent BN, Shaw RE. Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era: a report from the American College of Cardiology–National Cardiovascular Data Registry (ACC–NCDR). Catheter Cardiovasc Interv. 2006;68(6):867–872
  18. Park SJ, Park DW. PREmier of Randomized COMparison of Bypass Surgery Versus AngioplasTy Using Sirolimus-Eluting Stent in Patients With Left Main Coronary Artery Disease (PRE-COMBAT Trial). March 3, 2007. http://clinicaltrials.gov/show/NCT00422968.
  19. Mehilli J. Prospective, randomized trial of the sirolimus-eluting stent and paclitaxel-eluting stent for the treatment of unprotected left main coronary artery disease (ISAR-LEFT-MAIN). March 3, 2007. http://clinicaltrials.gov/show/NCT00133237.
  20. Boudriot E, Schuler G. PCI with DES versus CABG for patients with significant left main stenosis. March 3, 2007. http://clinicaltrials.gov/show/NCT00176397.
  21. Carrié D, Eltchaninoff H. French Multicenter Study assessing angioplasty with taxus drug eluting stent in unprotected left main coronary artery associated to other coronary lesions or not. March 3, 2007. http://clinicaltrials.gov/show/NCT00300157.
  22. Das P, Meredith I. Role of intravascular ultrasound in unprotected left main percutaneous coronary intervention. Expert Rev Cardiovasc Ther. 2007;5(1):81–89

PII: S1553-8389(07)00262-X

doi: 10.1016/j.carrev.2007.03.172

Cardiovascular Revascularization Medicine
Volume 8, Issue 3 , Pages 209-212 , July 2007